Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease--a report of the NAPRTCS.

@article{Dharnidharka2008RecombinantGH,
  title={Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease--a report of the NAPRTCS.},
  author={Vikas R Dharnidharka and Lynya I Talley and Karen L Martz and Donald M. Stablein and Richard N. Fine},
  journal={Pediatric transplantation},
  year={2008},
  volume={12 6},
  pages={689-95}
}
rhGH, widely used to optimize linear growth in children with ESRD, also modulates B-cell precursor development and may be associated with malignancy development. To determine if rhGH use in children was associated with higher risk of PTLD, we analyzed retrospectively collected data on children with CRI, on dialysis or with renal transplants in a large multi… CONTINUE READING